⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DFTX News
Definium Therapeutics, Inc. Common Shares
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
prnewswire.com
GHRS
HELP
DFTX
JNJ
CMPS
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
prnewswire.com
GHRS
HELP
DFTX
ATAI
CMPS
LLY
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
globenewswire.com
HELP
DFTX
CMPS
GHRS
JNJ
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
prnewswire.com
GHRS
HELP
DFTX
CMPS
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
businesswire.com
DFTX
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
businesswire.com
DFTX
Form 8-K
sec.gov
DFTX
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
businesswire.com
DFTX